Publications by authors named "Tal Z Zaks"

Claim this Profile
T
Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors.
Matthew D Galsky, Daniel D Von Hoff, Marcus Neubauer, Thomas Anderson, Mark Fleming, Tal Z Zaks

Invest New Drugs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer.
Helen J Ross, George R Blumenschein, Joseph Aisner, Nevena Damjanov, Afshin Dowlati, Tal Z Zaks

Clin Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.
Stephen Johnston, Maureen Trudeau, Bella Kaufman, Hamouda Boussen, Kimberley Blackwell, Tal Z Zaks

J Clin Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization.
Joel Greshock, Katherine Nathanson, Anne-Marie Martin, Lin Zhang, George Coukos, Tal Z Zaks

Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
Tara L Naylor, Joel Greshock, Yan Wang, Theresa Colligon, Q C Yu, Tal Z Zaks

Breast Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis